tosis in skeletal muscle plays an important role in age-and diseaserelated tissue dysfunction. Physical activity can influence apoptotic signaling; however, this process has not been well studied in human skeletal muscle. The purpose of this study was to perform a comprehensive analysis of apoptosis-related proteins/enzymes, DNA fragmentation, and oxidative stress in skeletal muscle of humans during an acute bout of prolonged moderate-intensity exercise. Eight healthy, recreationally active individuals (age 20.8 Ϯ 0.5 yr, V O2peak 51.2 Ϯ 0.9 ml · kg Ϫ1 · min Ϫ1 , BMI 21.5 Ϯ 0.8 kg/m 2 ) exercised on a cycle ergometer at ϳ60% V O2peak for 2 h. Muscle biopsies were obtained at rest as well as at 60 and 120 min of exercise. Although exercise was associated with a significant whole body and muscle metabolic response, there were no significant changes in the content of antiapoptotic (ARC, Bcl-2, Hsp70, XIAP) and proapoptotic (AIF, Bax, Smac) proteins, activity of proteolytic enzymes (caspase-3, caspase-8, caspase-9), DNA fragmentation, or TUNEL-positive nuclei in skeletal muscle. Furthermore, the protein levels of several antioxidant enzymes (catalase, CuZnSOD, MnSOD), concentrations of GSH and GSSG, and degree of ROS generation in skeletal muscle were not altered by exercise. Fiber type-specific analysis also revealed that ARC (P Ͻ 0.001) and Hsp70 (P Ͻ 0.05) protein were significantly higher in type I compared with type IIA and type IIAX/X fibers; however, protein levels were not affected by exercise. These findings suggest that a single bout of prolonged moderate-intensity aerobic exercise is not sufficient to alter apoptotic signaling in skeletal muscle of healthy humans. physical activity; cell death; oxidative stress; apoptosis repressor with caspase recruitment domain; heat shock protein 70 APOPTOSIS IS A HIGHLY CONSERVED cellular process that plays an important role in normal tissue development and homeostasis as well as in the pathogenesis of disease (18, 58). Apoptotic signaling is governed primarily by two pathways. The intrinsic pathway involves signaling and subsequent release of apoptotic factors [i.e., apoptosis-inducing factor (AIF), second mitochondria-derived activator of caspases (Smac), and cytochrome c] from the mitochondria. These mitochondrial-derived factors can either activate a cascade of proteolytic enzymes known as caspases (i.e., caspase-9 and caspase-3) or translocate directly to the nucleus and induce DNA fragmentation, ultimately leading to apoptosis (74). The extrinsic pathway involves activation of several death receptors (i.e., tumor necrosis factor receptor) by their corresponding ligands, which can also lead to caspase activation (e.g., caspase-8 and caspase-3), DNA fragmentation, and apoptosis (35). A number of regulatory factors such as the Bcl-2 family of proteins (i.e., Bcl-2 and Bax), the inhibitors of apoptosis protein family (i.e., XIAP), and heat shock proteins (i.e., Hsp70) also play central roles in mediating apoptosis (7, 15, 36, 79) .
activation of several death receptors (i.e., tumor necrosis factor receptor) by their corresponding ligands, which can also lead to caspase activation (e.g., caspase-8 and caspase-3), DNA fragmentation, and apoptosis (35) . A number of regulatory factors such as the Bcl-2 family of proteins (i.e., Bcl-2 and Bax), the inhibitors of apoptosis protein family (i.e., XIAP), and heat shock proteins (i.e., Hsp70) also play central roles in mediating apoptosis (7, 15, 36, 79) .
Although many of the apoptotic signaling pathways and molecules that govern apoptosis are similar between tissues, skeletal muscle is unique in some respects. Under most conditions, apoptosis results in the elimination of the cell. However, skeletal muscle is a multinucleated tissue wherein individual nuclei can undergo DNA fragmentation (5, 16) . Therefore, it has been proposed that apoptotic signaling in skeletal muscle may result in a distinct mode of apoptosis that does not necessarily result in loss of the entire cell but rather a loss of specific nuclei. As such, apoptosis in multinucleated cells such as skeletal muscle fibers has been referred to as "nuclear apoptosis" (6) . Skeletal muscle also contains two distinct mitochondrial fractions (subsarcolemmal and intermyofibrillar) with differential susceptibility to apoptotic stimuli (2) , and mitochondrial content can vary between muscle/fiber types. Given the importance of mitochondria in apoptosis, variations in mitochondrial content could differentially influence apoptotic signaling across muscle/fiber types. Finally, skeletal muscle contains high levels of apoptosis repressor with caspase recruitment domain (ARC); an antiapoptotic protein that can inhibit mitochondrial-and death receptor-mediated apoptosis (33, 45) .
Skeletal muscle DNA fragmentation and apoptotic signaling are altered during aging as well as several disease states (4, 69, 73, 77) . It has also been shown that exercise can alter apoptotic signaling and programmed cell death in a number of tissues, including skeletal muscle (9, 63, 3, 76) . For example, regular treadmill exercise positively influences apoptosis-specific protein and mRNA expression and decreases DNA fragmentation in rat skeletal muscle (40, 63, 66) . In contrast, acute exercise has been associated with augmented skeletal muscle apoptotic signaling. In healthy mice and rats, a single night of spontaneous wheel running increases myonuclei apoptosis (8, 51, 59 ) and alters Bcl-2 family protein expression (51) . Similarly, a single bout of treadmill running in healthy rats results in increased skeletal muscle caspase activity and appearance of apoptotic nuclei, effects which may be mediated by increased skeletal muscle oxidative stress (32) . Acute exercise in healthy humans has also been shown to alter skeletal muscle Bcl-2 family gene (39, 80) and protein expression (28) as well as caspase-3 mRNA levels (80) , protein content, and proteolytic activity (78) .
Although the level of apoptosis is relatively low in healthy skeletal muscle, the previous literature suggests that acute exercise in healthy animals and humans can alter apoptotic signaling. To date, these studies have examined some aspects of apoptosis in skeletal muscle during acute exercise; however, a comprehensive evaluation of apoptosis-related proteins, enzymes, and DNA fragmentation has not been conducted in human skeletal muscle. Furthermore, of the previous studies examining the effect of acute exercise on skeletal muscle apoptosis in humans (28, 39, 68, 78, 80) , only one has employed aerobic exercise (39) . Therefore, the purpose of this study was to conduct a broad analysis of apoptotic signaling in human skeletal muscle during prolonged, moderate-intensity aerobic exercise. Moreover, given that oxidative stress has been associated with exercise (48, 52, 55) and can induce apoptosis (27, 50, 64) , we also measured several antioxidants and reactive oxygen species (ROS) generation in skeletal muscle. In addition, we conducted fiber type-specific analysis of two proteins: 1) ARC, an antiapoptotic protein highly expressed in skeletal muscle (33, 54) that is rapidly downregulated in response to apoptotic stimuli (45, 46, 47) , and 2) Hsp70, a cytoprotective protein that can inhibit apoptosis (27, 67, 71) and has been shown to be induced in response to a number of cellular stressors (34, 67, 71) , including exercise (43, 44, 70) .
MATERIALS AND METHODS
Subjects. Eight healthy, recreationally active subjects (7 males and 1 female; age 20.8 Ϯ 0.5 y, V O2peak 51.2 Ϯ 0.9 ml · kg Ϫ1 · min Ϫ1 , BMI: 21.5 Ϯ 0.8 kg/m 2 ) participated in the study. All subjects were fully informed both orally and in writing of the purpose of the experiments and of any possible risks before giving written consent. All procedures were approved by the University of Guelph and McMaster University Research Ethics Boards and conformed with the Declaration of Helsinki.
Subjects visited the laboratory following a 12-h overnight fast on three separate occasions and were asked to refrain from performing exercise for a period of 48 h prior to each visit. On the first visit, peak pulmonary O 2 uptake (V O2peak) was determined with a metabolic cart (Vmax Series 229, Sensormedics) during an incremental exercise protocol performed on a cycle ergometer (LODE Instrument). On the second visit, subjects cycled at a workload equivalent to ϳ60% V O2peak for 2 h on the same cycle ergometer. This second visit was used to confirm the workload required to attain ϳ60% V O2peak and to familiarize subjects with the 2-h experimental procedure.
Experimental protocol. On the third visit, subjects rested on a bed while a catheter was inserted into an antecubital vein. A resting venous blood sample was taken, and saline drip was used to maintain a patent line. Both legs of the subject were also prepared for biopsies of the vastus lateralis muscle, and a resting sample was obtained under local anesthesia (2% Lidocaine without epinephrine) from leg 1 using the needle biopsy technique described by Bergström et al. (12) . Subjects then exercised on a cycle ergometer at ϳ60% V O2peak for 2 h, and additional blood samples were taken at 15, 30, 60, 90, and 120 min. Heart rate and respiratory gases were collected between 13-17, 28 -32, 55-59, 86 -90, and 115-119 min of exercise for the measurements of V O2 and V CO2 and calculation of the respiratory exchange ratio (RER). Additional muscle biopsies were obtained at 60 min (leg 2) and 120 min (leg 1) of exercise. Immediately following each biopsy, muscle was blotted to remove excess blood and dissected of any visible fat and connective tissue. The majority of the muscle sample was quickly frozen in liquid nitrogen and stored at Ϫ80°C for subsequent biochemical and molecular analysis. A small section at each time point was also embedded in OCT compound (Tissue-Tek), frozen in liquid nitrogen-cooled isopentane, and stored at Ϫ80°C for subsequent immunohistochemical and histochemical analyses.
Blood and muscle analyses. Venous blood was collected in sodiumheparin tubes. A 200-l aliquot of blood was added to 800 l of 0.6 M perchloric acid (HClO 4) and centrifuged, and the supernatant was analyzed for blood glucose and lactate using fluorometric techniques (11) . A second portion (1.5 ml) was centrifuged and the plasma analyzed for free fatty acids (FFA) using an enzymatic colorimetric technique (Wako NEFA C test kit, Wako Chemicals). A portion of the frozen muscle biopsies was freeze-dried, powdered, and dissected free of visible connective tissue, fat, and blood. An aliquot of freeze-dried powdered muscle (ϳ10 mg) was extracted in 0.5 M HClO 4-l mM EDTA and neutralized with 2.2 M KHCO 3. The supernatant was used to measure phosphocreatine (PCr), ATP, and lactate fluorometrically. A second and third aliquot (2-4 mg each) were extracted in 0.1 M NaOH and neutralized with 0.1 M HCl-0.2 M citric acid-0.2 M Na 2PO4, and amyloglucosidase was added to break down glycogen to glucose, which was measured in duplicate spectrophotometrically (11) . Freeze-dried muscle measurements were normalized to the highest total creatine content measured among the three biopsies from each subject.
Immunoblot analyses. Skeletal muscle (ϳ15 mg) was homogenized in ice-cold lysis buffer (20 mM HEPES, 10 mM NaCl, 1.5 mM MgCl, 1 mM DTT, 20% glycerol and 0.1% Triton X-100; pH 7.4) containing protease inhibitors (Complete Cocktail, Roche Diagnostics) using a glass homogenizer. Homogenates were centrifuged at 1,000 g for 10 min at 4°C, the supernatant was collected, and protein was determined by the BCA protein assay.
Equal amounts of protein were loaded and run on a 12% SDS-PAGE gel, transferred onto PVDF membrane (Roche Diagnostics), and blocked overnight with 10% milk-TBS-T at 4°C. Membranes were incubated at room temperature for 1 h with primary antibodies against apoptosis-inducing factor (AIF), apoptosis repressor with caspase recruitment domain (ARC), Bcl-2, Bax (Santa Cruz Biotechnology), copper-zinc superoxide dismutase (CuZnSOD), manganese superoxide dismutase (MnSOD), heat shock protein 70 (Hsp70), X-linked inhibitor of apoptosis protein (XIAP) (Stressgen Bioreagents), catalase (Chemicon), and second mitochondria-derived activator of caspases (Smac) (Assay Designs). Membranes were then washed and incubated with the appropriate horseradish peroxidaseconjugated secondary antibodies (Santa Cruz Biotechnology) for 1 h at room temperature, and bands were visualized using Enhanced Chemiluminescence Western Blotting Detection Reagents (GE Healthcare) and the ChemiGenius 2 Bio-Imaging System (Syngene). The approximate molecular weight for each protein was estimated using Precision Plus Protein WesternC Standards in conjunction with Precision Protein Strep-Tactin HRP Conjugate (Bio-Rad Laboratories). Equal loading and quality of transfer were confirmed by Ponceau S (Sigma-Aldrich) staining. All immunblot analyses were performed in duplicate. Relative protein levels are expressed as mean optical density in arbitrary units (AU).
Caspase proteolytic enzyme activity. Proteolytic enzyme activity of caspase-3, caspase-8, and caspase-9 was determined in muscle homogenate using the substrates Ac-DEVD-AMC (Alexis Biochemicals), Ac-IETD-AMC (Sigma-Aldrich), and Ac-LEHD-AMC (Alexis Biochemicals), respectively. These fluorogenic substrates are weakly fluorescent but yield highly fluorescent products following proteolytic cleavage by their corresponding active caspase enzyme. Briefly, ϳ15 mg of tissue was homogenized in ice-cold lysis buffer not containing protease inhibitors and centrifuged at 1,000 g for 10 min at 4°C. Tissue supernatants were then incubated with the appropriate substrate at room temperature for 1 h. Fluorescence was measured using a SPECTRAmax Gemini XS microplate spectrofluorometer (Molecular Devices) with excitation and emission wavelengths of 360 and 440 nm, respectively. As a positive control for caspase proteolytic activity, the appropriate substrate was incubated with human recombinant active caspase-3 (Alexis Biochemicals), caspase-8 (Sigma-Aldrich), or caspase-9 (Alexis Biochemicals). In all cases, a strong fluorescent signal was obtained (data not shown). Furthermore, control experiments using the caspase-3, caspase-8, and caspase-9 inhibitors Ac-DEVD-CHO (Alexis Biochemicals), Ac-IETD-CHO (SigmaAldrich), and Ac-LEHD-CHO (Alexis Biochemicals), respectively, completely inhibited the fluorescent signal observed from both the active recombinant enzymes and muscle samples (data not shown). Caspase activity was normalized to total protein content and expressed as mean fluorescence intensity in arbitrary units per milligram of protein.
ROS generation. ROS generation was determined as previously described (10, 54) , with modifications using 2=,7=-dichlorodihydrofluorescein-diacetate (DCFH-DA). DCFH-DA is hydrolyzed by intracellular esterases to form nonfluorescent dichlorofluorescein (DCFH), which can then be oxidized by a variety of ROS to form highly fluorescent DCF (61) . Briefly, muscle was homogenized in ice-cold phosphate-buffered saline (PBS; pH 7.4) using a glass homogenizer. Duplicates of muscle homogenate were preincubated with the ROS scavenger Tiron (1 mM), or left untreated. Samples were then incubated in the dark with 5 M DCFH-DA (Invitrogen) at 37°C. Fluorescence was measured every 15 min for 1 h using a SPECTRAmax Gemini XS microplate spectrofluorometer (Molecular Devices) with excitation and emission wavelengths of 490 and 525 nm, respectively. Fluorescence intensity was normalized to total protein content and expressed as arbitrary units per milligram of protein.
Glutathione detection. Reduced glutathione (GSH) and oxidized glutathione (GSSG) were determined by HPLC according to Reed et al. (50) . Briefly, ϳ20 mg of skeletal muscle was prepared in a 1:10 dilution of homogenizing medium (2 mM phenanthroline in 7% perchloric acid) using a glass homogenizer, and centrifuged at 1,000 g for 10 min at 4°C. A portion of the supernatant (125 l) was removed, treated with 5 l of 0.4 M iodoacetic acid, and neutralized with excess NaHCO 2. Samples were then incubated in the dark at room temperature for 1 h, treated with 1 l of alcoholic 1-fluoro-2,4-dinitrobenzene (1.5 ml/98.5 ml absolute ethanol), and incubated in the dark for 8 h. A 25-l portion of each sample was run on a Waters Alliance 2695 system using a Varian (Rainin) Microsorb 5 M amino (25 ϫ 4.5 cm) column at room temperature for 35 min with a flow rate of 1 ml/min and detection at 350 nm.
Detection of apoptotic nuclei and DNA fragmentation. Skeletal muscle cross-sections were fixed in 4% formaldehyde for 20 min, washed in PBS, permeabilized with 0.5% Triton X-100 for 15 min, washed in PBS, and blocked in 5% goat serum for 15 min at room temperature. Cross-sections were then incubated with a primary antibody against ␤-dystroglycan (Santa Cruz Biotechnology) for 1 h at room temperature in a humidified chamber. Cross-sections were washed in PBS and incubated with a goat anti-mouse IgG-rhodamine (Santa Cruz Biotechnology) secondary antibody for 1 h in the dark in a humidified chamber at room temperature. This staining procedure allowed for visualization of the sarcolemma of each fiber.
Apoptotic nuclei were then identified by terminal deoxynucleotidyl transferase (TdT)-mediated nick-end labeling (TUNEL) using the FragEL DNA fragmentation detection kit (Calbiochem). Briefly, cross-sections stained for ␤-dystroglycan above were permeabilized with 20 g/ml proteinase K for 10 min, washed in TBS (20 mM Tris, 140 mM NaCl, pH 7.6), incubated in TdT equilibration buffer for 20 min, and washed in TBS, all at room temperature and in the dark. Cross-sections were then incubated with fluorescein-FragEL TdT labeling reaction mixture for 1 h at 37°C in a humidified chamber in the dark, washed three times with TBS, and counterstained with DAPI to visualize all nuclei. Apoptotic nuclei were counted only if colocalization of TUNEL and DAPI staining was observed. A control slide was also included that contained both viable and apoptotic HL-60 cells to verify positive and negative TUNEL staining. Slides were visualized on a Zeiss Axio Observer Z1 structured-illumination fluorescent microscope equipped with an AxioCam HRm camera and associated AxioVision software (Carl Zeiss).
Cytoplasmic histone-associated mono-and oligonucleosomes (i.e., DNA fragmentation) were determined using the Cell Death Detection ELISA PLUS Kit (Roche Diagnostics) according to the manufacturer's protocol. Briefly, ϳ5 mg of muscle tissue was homogenized in lysis buffer and then centrifuged at 200 g for 10 min at room temperature. Duplicates of 20 l of supernatant were then incubated with 80 l of anti-histone-biotin/anti-DNA-POD reagent in a streptavidin-coated microplate for 2 h at room temperature under gentle shaking. Then, 100 l of ABTS substrate solution was added to each well and incubated for 60 min, and absorbance was measured at 405 and 490 nm using a SPECTRAmax Plus spectrophotometer (Molecular Devices). As a positive control for DNA fragmentation, a DNA-histone complex sample was included to confirm a positive signal (data not shown). Absorbance was normalized to total protein content and was expressed as arbitrary units per milligram of protein.
Immunohistochemical and histochemical analyses. Frozen skeletal muscle samples embedded in OCT compound were cut into 10-m serial cross-sections with a cryostat (Thermo Electronic) maintained at Ϫ20°C. Cross-sections were then fixed to microscope slides with 100% cold acetone for 10 min, washed for 5 min in PBS, permeabilized with 0.5% Triton X-100 (in PBS) for 5 min, and washed three times for 5 min in PBS. Cross-sections were then blocked with 5% horse (Hsp70) or goat (ARC) serum at room temperature for 30 min in a humidified chamber (70), followed by incubation with primary antibodies against ARC (Santa Cruz Biotechnology) and Hsp70 (Stressgen Bioreagents) for 1 h at room temperature. Cross-sections were washed three times for 5 min in PBS and incubated with biotinylated horse anti-mouse (Hsp70) or goat anti-rabbit (ARC) immunoglobulin G (Vector Laboratories) for 30 min at room temper- 
Values are means Ϯ SE; n ϭ 7-8. RER, respiratory exchange ratio. *Significantly different from 15 min (P Ͻ 0.05); †significantly different from Rest (P Ͻ 0.05). ature. The sections were rinsed three times for 5 min in PBS and then incubated with a horseradish peroxidase-streptavidin conjugate (Vector Laboratories) for 30 min at room temperature. ARC and Hsp70 protein expression was visualized using the NovaRED peroxidase secondary detection system (Vector Laboratories), which produces a brown-red precipitate. Staining intensities for ARC and Hsp70 protein were calculated by subtracting the background from a negative control slide (no primary antibody) as well as the background from an area not containing the cross-section on the slide incubated with the primary antibody. The resulting staining intensity was quantified with a microscope (Nikon) linked to a digital camera (PixeLink) in conjunction with computer-based imaging analysis software (Image-Pro PLUS) and expressed as mean optical density in arbitrary units.
Muscle fiber glycogen content was determined using the periodic acid-Schiff reaction as previously performed (70) . Muscle fiber type was determined by preincubation of serial cross-sections at pH 4.55 and 10.3, followed by Azure A staining for myosin ATPase activity (14) . Hybrid type IIAX fibers were not distinguished from pure type IIX fibers; rather, fibers staining intermediately following preincubation at pH 4.55 were classified as type IIAX/X. Collectively, this allowed for the determination of type I, type IIA, and type IIAX/X fibers. Myosin ATPase-stained cross-sections were imaged with the camera-based microscopy system above. Following fiber type determination, fibers were chosen (n ϭ 10 for each fiber type) from two random areas (ϳ75-100 fibers per region) of the myosin ATPasestained cross-section. These fibers were then matched to corresponding ARC-, Hsp70-, and glycogen-stained cross-sections to determine fiber type-specific expression. All cross-sections for a particular marker were stained and analyzed on the same day and were performed in duplicate.
Statistical analysis. Whole muscle data were analyzed using a one-way ANOVA, whereas fiber type-specific data were analyzed with a 3 (fiber type: type I, type IIA, type IIAX/X) ϫ 3 (time: rest, 60 min, 120 min) factorial ANOVA using SPSS analysis software. Tukey's HSD post hoc test was used to determine differences between means. For whole body, blood, and muscle metabolic data, post hoc comparisons were only made to rest or 15-min condition. In all cases, P Ͻ 0.05 was considered statistically significant. All results are given as means Ϯ SE.
RESULTS
Whole body, blood, and muscle metabolic measurements. Subjects cycled for 120 min at an average power output of 142.9 Ϯ 9.7 W, which represented 60.4 Ϯ 1.6% V O 2peak . V O 2 increased significantly (P Ͻ 0.05) from 2.13 Ϯ 0.13 l/min at 15 min of exercise to 2.36 Ϯ 0.11 l/min at 120 min of exercise (Table 1 ). The RER was 0.93 Ϯ 0.01 at 15 min of exercise and decreased significantly (P Ͻ 0.05) throughout exercise, reaching values of 0.87 Ϯ 0.01 at 90 and 120 min of exercise. Heart rate increased significantly (P Ͻ 0.05) from 152 Ϯ 2 beats/min at 15 min to 163 Ϯ 3 beats/min at 120 min of exercise (Table 1) .
Plasma FFA concentration was 0.48 Ϯ 0.07 mM at rest following the overnight fast and decreased significantly (P Ͻ 0.05) at 30 min of exercise until increasing significantly (P Ͻ 0.05) at 90 and 120 min of exercise (Table 1) . Whole blood glucose was 4.7 Ϯ 0.1 mM at rest and was significantly decreased (P Ͻ 0.05) at 15, 90, and 120 min of cycling. Whole blood lactate was 0.6 Ϯ 0.2 mM at rest, increased significantly (P Ͻ 0.05) by 15 min of exercise, and remained above resting values throughout exercise (Table 1) .
Resting muscle glycogen content was 469.6 Ϯ 15.0 mmol/kg dry muscle and significantly (P Ͻ 0.05) decreased by 65% during the first hour of cycling and a further 22% during the second hour (Table 2 ). There were modest but significant (P Ͻ 0.05) increases in muscle lactate at 60 and 120 min of exercise compared with rest. Resting muscle PCr was 83.0 Ϯ 2.4 mmol/kg dry muscle at rest and significantly (P Ͻ 0.05) decreased by 33% in the first hour and a further 23% in the second hour of cycling, whereas muscle ATP was unchanged throughout exercise (Table 2) .
Myosin-ATPase staining and fiber type-specific glycogen content. Representative skeletal muscle cross-sections showing myosin-ATPase staining following preincubation at pH 4.55 are shown in Fig. 1, A-C . The observed staining pattern allows for the discrimination of type I, type IIA, and type IIAX/X fibers. Additional analysis was performed following preincubation of muscle cross-sections at pH 10.3 to confirm fiber type (data not shown). The mean fiber type distribution in the vastus lateralis muscle of our subjects was 48.69 Ϯ 2.00% type I, 42.85% Ϯ 2.16% type IIA, and 8.46% Ϯ 2.63% type IIAX/X.
Muscle glycogen content, as determined by the periodic acid-Schiff reaction, is shown in Fig. 1 , D-F. Glycogen content was significantly lower (P Ͻ 0.01) in type I compared with type IIA, and type IIAX/X fibers (Fig. 1G) . Across all fiber types, glycogen content was significantly (P Ͻ 0.001) reduced by 46 and 78% at 60 and 120 min of exercise, respectively, compared with rest. The glycogen response to exercise observed in muscle cross-sections was similar to that in whole muscle (see above). The observed fiber type-specific glycogen utilization also suggests that all three fiber types were recruited during exercise.
Skeletal muscle apoptotic signaling, TUNEL staining, and DNA fragmentation. The expression of apoptosis-related proteins was evaluated in skeletal muscle homogenates by immunoblot analysis. The level of the antiapoptotic proteins ARC, Bcl-2, XIAP, and Hsp70 were not significantly altered by exercise (Fig. 2, A and B) . Similarly, the level of the proapoptotic proteins AIF, Bax, and Smac were not significantly affected by exercise at either time point (Fig. 3, A and B) . Analysis of the Bcl-2-to-Bax ratio, often used as a marker of susceptibility to apoptotic stress, was not significantly different at either time point (rest, 1.00 Ϯ 0.08; 60 min, 0.97 Ϯ 0.12; 120 min, 0.94 Ϯ 0.17 AU).
The activity of apoptosis-related proteolytic enzymes was evaluated by fluorescent spectroscopy in skeletal muscle homogenates. The activity of the initiator caspases, caspase-8 and caspase-9, were not significantly affected by exercise (Fig. 4) . Similarly, the activity of the executioner caspase, caspase-3, was not altered by exercise (Fig. 4) . The activity of each of these caspase enzymes was almost completely eliminated when muscle samples were preincubated with specific caspase-3, caspase-8, and caspase-9 inhibitors (data not shown).
Apoptotic nuclei in muscle cross-sections were examined using three-color fluorescent microscopy. Nuclei residing within the sarcolemma were identified as myonuclei, whereas nuclei located outside the sarcolemma were considered to belong to interstitial cells (i.e., stromal cells, satellite cells). Although several TUNEL-positive nuclei (myonuclei and from interstitial cells) were identified, TUNEL-positive nuclei were not detected on most muscle cross-sections (Fig. 5, A and B) . The number of TUNEL-positive myonuclei and interstitial cells was not altered by exercise. Consistent with the above findings, the level of DNA fragmentation, as determined by ELISA in muscle homogenate, was not significantly altered by exercise (Fig. 5C) .
Immunohistochemical analyses. Immunohistochemical analysis of fiber type-specific protein expression in muscle crosssections revealed that ARC was significantly (P Ͻ 0.001) higher in type I compared with type IIA and type IIAX/X fibers (Fig. 6, A-C ). There were no differences between type IIA and type IIAX/X fibers. In addition, the expression of ARC protein was not altered in any fiber type in response to exercise (immunohistochemical data not shown). Similarly, immunohistochemical analysis of Hsp70 protein expression in skeletal muscle cross-sections revealed significantly (P Ͻ 0.05) higher levels in type I compared with type IIA and type IIAX/X fibers (Fig. 7, A-C ). There were no differences between type IIA and type IIAX/X fibers. Furthermore, acute exercise did not affect Hsp70 expression in any fiber type (immunohistochemical data not shown).
Skeletal muscle antioxidant levels and ROS generation. The protein content of several antioxidant enzymes was determined in skeletal muscle by immunoblot analysis. As shown in Fig. 8,  A and B, the levels of CuZnSOD and MnSOD were not significantly altered by acute exercise. Compared with rest, the protein content of catalase increased by ϳ35 and ϳ38% at 60 and 120 min of exercise, respectively; however, this did not reach statistical significance. The concentration of GSH was not significantly different with exercise (rest, 2.72 Ϯ 0.24; 60 min, 2.11 Ϯ 0.32; 120 min, 2.45 Ϯ 0.17 mmol/kg wet muscle). There was a trend toward a higher concentration of GSSG at 120 min exercise (rest, 0.14 Ϯ 0.03; 60 min, 0.13 Ϯ 0.02; 120 min, 0.21 Ϯ 0.02 mmol/kg wet muscle); however, this did not reach statistical significance (P ϭ 0.09). The GSH/GSSG ratio was not significantly affected by exercise (data not shown).
Skeletal muscle homogenate steadily generated ROS over time, as indicated by DCFH oxidation (data not shown). Following 1 h of incubation, ROS generation was not significantly different with exercise (rest, 1.00 Ϯ 0.16; 60 min, 1.12 Ϯ 0.10; 120 min, 1.04 Ϯ 0.14 AU/mg protein). Incubation of samples with the ROS scavenger Tiron significantly (P Ͻ 0.001) reduced DCFH oxidation by ϳ70 -75% across all conditions (data not shown), further confirming that the fluorescent signal obtained was due to ROS generation. This latter finding is not surprising given that reactive nitrogen species (RNS) such as nitric oxide (NO) can be produced in skeletal muscle (31, 52) and can also oxidize DCFH (60, 61) .
DISCUSSION
In the present study, we investigated the effect of an acute bout of prolonged, moderate-intensity aerobic cycling on skeletal muscle apoptosis and oxidative stress. As expected, exercise was associated with a significant whole body and muscle metabolic response. Cycling for 2 h at 60% V O 2peak resulted in significantly elevated blood and muscle lactate levels as well as reduced blood glucose, muscle glycogen, and PCr content. Despite these significant whole body and muscle metabolic responses, exercise did not alter the whole muscle expression of several antiapoptotic (ARC, Bcl-2, Hsp70, XIAP) or proapoptotic (AIF, Bax, Smac) proteins. Immunohistochemical analysis confirmed our immunoblot analyses, demonstrating that exercise did not alter ARC or Hsp70 protein expression across any fiber type. We also failed to show any differences in the activity of several apoptosis-related proteolytic enzymes (caspase-3, caspase-8, and caspase-9) or the level of DNA fragmentation in whole muscle and number of apoptotic nuclei (myonuclei and from interstitial cells) in skeletal muscle in response to exercise. Furthermore, exercise was not associated with any significant changes in skeletal muscle redox status, as indicated by no change in antioxidant enzyme (catalase, CuZnSOD, MnSOD) protein levels, GSH and GSSG concentrations, or ROS generation. In addition to these exercise-related data, we show for the first time that ARC and Hsp70 protein are differentially expressed across fiber types in human skeletal muscle.
Apoptosis is a highly conserved cellular process that plays an important role in tissue homeostasis and the pathogenesis of disease (18, 58) . ARC is an antiapoptotic protein that is primarily found in terminally differentiated cells such as skeletal muscle and heart (1, 17, 33, 47) . Given the high expression of ARC in skeletal muscle and that skeletal muscle does not normally undergo high rates of apoptosis (1, 33) , ARC likely plays an essential role in regulating skeletal muscle apoptosis. The important antiapoptotic function of ARC is further supported by the fact that ARC gene and/or protein expression is low or absent in several healthy tissues (i.e., liver, lung, kidney) with normal rates of apoptosis (1, 33, 47) but greatly elevated in cancerous cells, which tend to be resistant to apoptosis (26, 42, 75) . Furthermore, unlike most antiapoptotic factors that mediate their action at one of the major pathways, ARC is able to inhibit apoptosis mediated by both the mitochondrial and death receptor pathways (33, 45) .
For the first time, we show that ARC protein is differentially expressed across fiber types in human skeletal muscle. Our data revealed that basal ARC protein levels were ϳ23 and ϳ27% higher in type I compared with type IIA and type IIAX/X fibers, respectively. A previous study in mouse skeletal muscle found that ARC protein was nonuniformly expressed across fibers and highly expressed in oxidative fibers (1) . Although those authors did not distinguish between fiber types by using myosin heavy-chain staining, this is in agreement with our novel data given that it has been widely documented that type I human muscle fibers are highly oxidative compared with type II fibers (24, 25) . ARC has been reported to be localized to the mitochondria, cytosol, and nucleus of cells, and its location can influence its apoptotic function (17, 37, 42, 75) .
Our immunohistochemical data show strong cytoplasmic ARC staining; however, the subcellular distribution of ARC in human muscle needs further clarification. It remains to be determined whether the differential ARC distribution in type I fibers is directly related to mitochondrial content or other inherent morphological and/or functional properties.
Using immunohistochemical analysis, we also demonstrate for the first time in human muscle that basal Hsp70 protein content is significantly higher in type I compared with both type IIA and type IIAX/X fibers. This is consistent with previous data in rodents showing higher Hsp70 protein in muscle composed of predominantly type I (i.e., soleus) than type II (i.e., white gastrocnemius) fibers (38, 43) . It has been shown that basal Hsp70 content in rat skeletal muscle is restricted to oxidative type I and type IIA fibers, with the highest levels in type IIA fibers (49) . The lower Hsp70 levels observed in the type IIA fibers in our human data compared with the previous animal research are likely a reflection of the inherent differences in this fiber type between species. For example, type IIA fibers in human muscle have a lower oxidative potential than type I fibers (24, 25) , whereas the reverse has been demonstrated in rat muscle (23, 65) . It remains to be determined whether metabolic as well as other factors (i.e., contractile/recruitment properties) influence basal Hsp70 expression in human muscle. Together, the higher expression of two potent antiapoptotic proteins (ARC and Hsp70) in type I fibers suggests that there may be differences in apoptotic signaling/susceptibility across different muscles and fiber types. It remains to be determined whether human type I muscle fibers are less susceptible to apoptosis than type II fibers, given these novel findings.
To date, only a handful of studies have examined the effect of exercise on a limited number of apoptotic markers in human skeletal muscle (3, 28, 39, 68, 78, 80) . Eccentric exercise has been shown to increase postexercise levels of caspase-3 protein and activity (78) , as well as elevate Bcl-2 (28, 68) and Bax protein content (28) in skeletal muscle; however, eccentric exercise did not alter skeletal muscle DNA fragmentation (28). Yang et al. (80) found postexercise increases in caspase-3 (4 and 24 h) and Bax (24 h) but not Bcl-2 mRNA following resistance exercise (80) . High-intensity endurance cycling to exhaustion (ϳ75 min) significantly decreased proapoptotic Bid gene levels but increased antiapoptotic Bcl-2-like 10 gene expression 3 h postexercise (39) . In addition to these acute exercise studies, endurance training for 14 wk was shown to elevate muscle Bax but not AIF or Bcl-2 protein content (3). To date, the present study is the most comprehensive examination of apoptotic signaling and apoptosis in human skeletal muscle in response to exercise. Our results show that cycling at 60% V O 2peak for 2 h does not alter a number of the major antiapoptotic (ARC, Bcl-2, Hsp70, XIAP) or proapoptotic (AIF, Bax, Smac) proteins and enzymes (caspase-3, caspase-8, caspase-9) involved in apoptosis. In addition, we did not observe any differences in the level of DNA fragmentation or TUNEL-positive nuclei, hallmarks of apoptosis. Although our measurements were limited to 60 and 120 min of exercise, changes in some markers of apoptotic signaling would be expected at these time points if apoptosis was occurring. For example, treadmill running in rats lasting ϳ52 min has been shown to increase nuclei apoptosis as well as elevate caspase-3 and caspase-9 activity in skeletal muscle immediately after exercise (32) . Furthermore, it has been reported that ARC protein is rapidly downregulated within 1-2 h following exposure of cells to apoptotic stimuli such as oxidant stress (45, 46) , an effect not accounted for by changes in ARC mRNA abundance (46) . Collectively, these data suggest that moderate prolonged aerobic exercise is not sufficient to alter apoptotic signaling and apoptosis in human skeletal muscle.
Oxidative stress can induce myocyte apoptosis in vitro (27, 64) and has been associated with elevated skeletal muscle apoptosis in vivo (13, 32) . Exercise has been shown to lead to oxidative stress (i.e., increased ROS formation, altered antioxidant levels, and oxidative damage to lipids, proteins, and/or DNA) in a number of animal and human tissues (reviewed in Refs. 48, 52, 55) . It has been demonstrated that aerobic cycling increases SOD activity (29) and decreases total GSH levels (with a tendency toward lower reduced GSH levels) but has no effect on GSSG concentrations (41) and catalase activity (29) in human skeletal muscle. Others have reported that a single bout of aerobic exercise in humans does not alter MnSOD protein levels, SOD or catalase activity (44), or total GSH, GSSG, ␣-tocopherol, and uqiquitone concentrations (57) in skeletal muscle. Similarly, we did not detect any changes in skeletal muscle antioxidant enzyme protein levels (catalase, CuZnSOD, MnSOD), GSH or GSSG concentrations, or ROS generation following prolonged, moderate-intensity exercise. Given these discrepancies, along with the limited reports examining oxidative stress in human skeletal muscle in response to acute, nondamaging endurance exercise, further work in this area is needed.
Hsp70 is an effective inhibitor of apoptosis (27, 67, 71) . Several reports in humans have shown that Hsp70 protein increases immediately after exercise (21, 70) ; however, this has not been supported by others (20, 22, 53) . A recent report by Tupling et al. (70) demonstrated that immunohistochemical analysis was able to detect a fiber type-specific Hsp70 response immediately following exercise, an effect not observed in whole homogenate by immunoblot analysis. In the present study, we did not observe changes in Hsp70 protein during or immediately following 2 h of exercise, using both immunoblot and immunohistochemical analysis. It is possible that the Hsp70 response in this study was delayed, as higher skeletal muscle Hsp70 protein levels have been reported several days postexercise (29, 30, 44, 70) . Given the wide variety of exercise protocols used in the literature to date, comparisons across studies are difficult and further work is warranted. In the present investigation, we also found reduced whole muscle as well as fiber type-specific glycogen levels with exercise. It has been suggested that skeletal muscle Hsp70 mRNA and protein increase in response to reduced intramuscular glycogen stores (19, 21) . The findings from the present investigation are in agreement with a previous report (70) and suggest that reduced muscle glycogen availability is not associated with elevated muscle Hsp70 protein expression.
Collectively, the data presented in this investigation suggest that an acute bout of prolonged, moderate-intensity aerobic exercise in healthy humans is not associated with elevated skeletal muscle oxidative stress and apoptosis. We also provide evidence for fiber type-specific differences in apoptosis-related protein expression in human skeletal muscle. This latter finding illustrates the importance of considering skeletal muscle/fiber type differences in apoptosis research, particularly in physical activity studies, since different exercise protocols may result in distinct patterns of muscle/fiber type recruitment/activation. Future apoptosis studies in skeletal muscle should examine fiber type expression patterns of additional apoptosis-related proteins and determine how this may influence apoptotic signaling and susceptibility across different muscle/fiber types.
